Molecular links between centrosome duplication and other cell cycle-associated events

The Centrosome: Cell and Molecular Mechanisms of Functions and Dysfunctions in Disease

Volumn , Issue , 2012, Pages 173-186

  Fukasawa, K ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956679150     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-035-9_10     Document Type: Chapter

References (55)

1. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:20246–20249
2. Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR (1995) Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 130:105–115
3. Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A, Jansen-Durr P (1996) Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol 16:3401–3409
4. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C (2002) Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62:1129–1133
5. Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li YQ, Tarapore P, Fukasawa K (1999) Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18:1935–1944
6. Chevrier V, Piel M, Collomb N, Saoudi Y, Frank R, Paintrand M, Narumiya S, Bornens M, Job D (2002) The Rho-associated protein kinase p160ROCK is required for centrosome positioning. J Cell Biol 157:807–817
7. D’Assoro AB, Lingle WL, Salisbury JL (2002) Centrosome amplification and the development of cancer. Oncogene 21:6146–6153
8. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K (2000) The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A 97:10002–10007
9. Dulic V, Lees E, Reed SI (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958–1961
10. Ekholm SV, Zickert P, Reed SI, Zetterberg A (2001) Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol Cell Biol 21:3256–3265
11. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:692–695
12. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF (1996) Abnormal centrosome amplification in the absence of p53. Science 271:1744–1747
13. Fukasawa K, Wiener F, Vande Woude GF, and Mai S (1997) Genomic instability and apoptosis are frequent in p53 deficient mice. Oncogene 15:1295–1302
14. Fukasawa K, Vande Woude GF (1997) Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol 17:506–518
15. Fukasawa K (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6–19
16. Fukasawa K (2007) Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 7:911–924
17. Fukasawa K (2011) Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects. Horm Cancer 2:104–112
18. Furihata M, Ohtsuki Y, Sonobe H, Shuin T, Yamamoto A, Terao N, Kuwahara M (1998) Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter. Br J Cancer 77:783–788
19. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP (2005) Role of Nucleophosmin in embryonic development and tumorigenesis. Nature 437:147–153
20. Hanashiro K, Kanai M, Geng Y, Sicinski P, Fukasawa K (2008) Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells. Oncogene 27:5288–5302
21. Hanashiro K, Brancaccio M, Fukasawa K (2011) Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification. Oncogene 30:2188–2197
22. Haupt Y, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296–299
23. Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851–854
24. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH, Chang WC (2008) Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 36:4337–4351
25. Kanai M, Crowe MS, Zheng Y, Vande Woude GF, Fukasawa K (2010) RhoA and RhoC are both required for theROCKII-dependent promotion of centrosomeduplication. Oncogene 29:6040–6050
26. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG, Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG (2004) Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability–evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol 165:1351–1365
27. Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, Fukasawa K (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64:4800–4809
28. Keyomarsi K, Herliczek TW (1997) The role of cyclin E in cell proliferation, development and cancer. Prog Cell Cycle Res 3:171–191
29. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM (1992) Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689–1694
30. Kubbutat MH, Jones SN, Vousden K (1997) Regulation of p53 stability by Mdm2. Nature 387:299–303
31. Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci U S A 96:2817–2822
32. Leung T, Chen XQ, Manser E, Lim L (1996) The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16:5313–5327
33. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15:2208–2216
34. Ma Z, Kanai M, Kawamura K, Kaibuchi K, Ye K, Fukasawa K (2006) Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol 26:9016–9034
35. McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD (2006) p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 4:e51
36. Metge B, Ofori-Acquah S, Stevens T, Balczon R (2004) Stat3 activity is required for centrosome duplication in Chinese hamster ovary cells. J Biol Chem 279:41801–41806
37. Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE (2002) p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 12:1817–1827
38. Momand J, Zambetti G (1997) Mdm-2: “big brother” of p53. J Cell Biochem 64:343–352
39. Mussman JG, Horn HF, Carroll PE, Okuda M, Donehower LA, Fukasawa K (2000) Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19:1635–1946
40. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996) ROCK-I and ROCKII, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392:189–193
41. Nam HJ, Chae S, Jang SH, Cho H, Lee JH (2010) The PI3 K-Akt mediates oncogenic Metinduced centrosome amplification and chromosome instability. Carcinogenesis 31:1531–1540
42. Nevis KR, Cordeiro-Stone M, Cook JG (2009) Origin licensing and p53 status regulate Cdk2 activity during G(1). Cell Cycle 15:1952–1963
43. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan P-K, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K (2000) Nucleophosmin/B23 is a target of CDK2-cyclin E in centrosome duplication. Cell 103:127–140
44. Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa T, Hirao T, Nakano H (1998) Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 82:1238–1243
45. Sherline P, Mascardo RN (1982) Epidermal growth factor induces rapid centrosomal separation in HeLa and 3T3 cells. J Cell Biol 93:507–512
46. Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6:663–673
47. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512
48. Sugihara E, Kanai M, Saito S, Nitta T, Toyoshima H, Nakayama K, Nakayama KI, Fukasawa K, Schwab M, Saya H, Miwa M (2006) Suppression of centrosome amplification after DNA damage depends on p27 accumulation. Cancer Res 66:4020–4029
49. Tarapore P, Horn HF, Tokuyama Y, Fukasawa K (2001) Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 20:3173–3184
50. Tarapore P, Okuda M, Fukasawa K (2002) A mammalian in vitro centriole duplication system: Evidence for involvement of CDK2/cyclin E and Nucleophosmin/B23 in centrosome duplication. Cell Cycle 1:75–81
51. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803–1815
52. Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Brinkley BR, Roop DR (1998) Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53 172H mutant and p53-knockout mice after chemical carcinogenesis: evidence for a gain of function. Mol Carcinog 23:185–192
53. Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301:43–49
54. Zeng X, Shaikh FY, Harrison MK, Adon AM, Trimboli AJ, Carroll KA, Sharma N, Timmers C, Chodosh LA, Leone G, Saavedra HI (2010) The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene 29:5103–5112
55. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20:189–193